Optimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health System (OTIMAS)

Clinical trial NCT07376317 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07376317
Sponsor: Instituto do Cancer do Estado de São Paulo
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Metastatic Melanoma Recurrent Cutaneous Melanoma Stage IV Melanoma

Start date: 2021-12-10
Primary completion: 2027-01-30
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.